| 01:50 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 01:45 PM |
Notice Convening Extraordinary General Meeting (EGM) To Be Held On Tuesday, May 12, 2026 Through VC And OAVM
|
| 06:08 PM |
Board Meeting Outcome for Revised Outcome
|
| 05:02 PM |
Board Meeting Outcome for For Meeting Held On April 16, 2026 Of Gennex Laboratories Limited To Conduct EGM
|
| 01:59 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 03:29 PM |
Board Meeting Intimation for Meeting To Be Held On Thursday, April 16, 2026
|
| 05:14 PM |
Closure of Trading Window
|
| 02:18 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:12 PM |
Intimation Of Reconstitution Of Audit Committee, Stakeholders Relationship Committee And Nomination And Remuneration Committee Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015
|
| 05:54 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 05:25 PM |
Announcement under Regulation 30 (LODR)-Resignation of Director
|
| 05:00 PM |
Quarter And Nine Months Ended December 31, 2025
|
| 04:52 PM |
Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025
|
| 01:33 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:25 PM |
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31, 2025
|
| 06:27 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 05:51 PM |
Closure of Trading Window
|
| 02:30 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:29 PM |
Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025
|
| 05:14 PM |
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025
|
| 05:13 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 03:01 PM |
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2025
|
| 04:59 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 11:12 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
|
| 02:06 PM |
Shareholder Meeting / Postal Ballot-Outcome of AGM
|
| 03:31 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 02:44 PM |
Reg. 34 (1) Annual Report.
|
| 05:46 PM |
Intimation Of Book Closure For AGM
|
| 05:27 PM |
Board Meeting Outcome for For Meeting Held On 04Th September 2025 For Approval Of Board Reports And AGM Related Agenda
|
| 04:21 PM |
Board Meeting Intimation for Fixing Date, Time And Venue Of 40Th AGM Of The Company
|
| 01:29 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:28 PM |
Unaudited Financial Results For The Quarter Ended June 30, 2025
|
| 05:00 PM |
Board Meeting Outcome for Outcome Of The Board Meeting Of Gennex Laboratories Limited Held On August 14, 2025 For Unaudited Financial Results Of First Quarter Ended June 30, 2025
|
| 03:30 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 03:04 PM |
Approval Of Products From Drugs Control Administration,
Government Of Andhra Pradesh For Our Subsidiary Company,
Deccan Remedies Limited
|
| 02:38 PM |
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2025
|
| 03:26 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:37 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:06 PM |
Board Meeting Outcome for Board Meeting Held On July 08, 2025 For Conversion Of 55 Lakhs Warrants Into Equity Shares
|
| 06:53 PM |
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
|
| 03:08 PM |
Board Meeting Outcome for Board Meeting Held On July 04, 2025 For Conversion Of 60 Lacs Warrants Into Equity Shares
|
| 05:40 PM |
Closure of Trading Window
|
| 02:52 PM |
Board Meeting Outcome for Outcome Of The Board Meeting Of Gennex Laboratories Limited Held On June 04, 2025 For Conversion Of Warrants Into Equity Shares
|
| 03:39 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:48 PM |
Compliances-Reg.24(A)-Annual Secretarial Compliance
|
| 08:15 PM |
Appointment Of Mr. Sandeep Kumar Daga As Additional (Non-Executive Non Independent) Director Of The Company
|
| 07:47 PM |
Announcement under Regulation 30 (LODR)-Resignation of Director
|
| 07:34 PM |
Audited Financial Results For The Year Ended March 31, 2025
|
| 06:29 PM |
Board Meeting Outcome for Outcome Of Board Meeting Held On May 30, 2025 For Audited Financial Result For The Quarter And Year Ending March 31, 2025
|
| 04:54 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 01:21 PM |
Approval Of Additional Products From Drugs Control Administration, Government Of Andhra Pradesh For Our Subsidiary Company, Deccan Remedies Limited
|
| 04:26 PM |
Board Meeting Intimation for For Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2025
|
| 02:21 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 01:48 PM |
Closure of Trading Window
|
| 11:45 AM |
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
|
| 11:36 AM |
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
|
| 04:17 PM |
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
|
| 04:13 PM |
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
|
| 06:35 PM |
Integrated Filing (Financial)
|
| 06:50 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 07:00 PM |
Unaudited Financial Results For Quarter And Nine Months Ended December 31, 2024
|
| 06:44 PM |
Board Meeting Outcome for Outcome Of The Board Meeting Of Gennex Laboratories Limited
|
| 05:49 PM |
Statement Of Deviation Or Variation In The Use Of Proceeds Pursuant To Regulations 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. - Scrip Code: 531739/GENNEX
|
| 05:30 PM |
Announcement under Regulation 30 (LODR)-Resignation of Director
|
| 04:19 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 03:30 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 02:35 PM |
Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024
|
| 06:53 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback